866-282-5141

Get started now

Adults 65+ will be at highest risk for COVID if there’s a resurge—and will be the first to need a booster

There are 34 million confirmed cases of COVID-19 in the U.S. The virus has killed nearly 600,000 people. 80% of those deaths were among people aged 65 and over. The flu is another dangerous virus for that age group—and flu season is around the corner. Vaccines for both viruses have proved effective. But how long the coronavirus vaccine will protect the health of all recipients, especially those 65 and over, remains unknown.

We need to be ready. We need a booster.

Right now, local doctors are leading research studies to evaluate the effectiveness of a booster in people 65 and over who received the Moderna vaccine. These studies are simultaneously evaluating the Fluzone® high-dose flu vaccine, which is recommended for ages 65+. Some participants will receive a combination of the COVID booster and the flu vaccine. Others will receive only the booster. Still others will receive only the vaccine for flu.

By participating, you’ll help clinical research fight the COVID pandemic and the flu. You can make a difference.

Take the next step to see if you qualify for local booster shot research studies for people 65+ vaccinated with Moderna. But don’t delay — space is limited!

Get started now

How does it work?

1

Tell us a little bit about yourself

2

Answer some questions about your health

3

We will connect you to available studies in your area

Just takes a few minutes

Get started now

COVID-19 update — we remain open.

For the safety of both staff and patients, we require that our research sites are COVID-19 SMART facilities. That means they use best practices to reduce virus exposure and are dedicated to ensuring they remain open and available for the research of investigational medications.

COVID-19 SMART steps we are taking to ensure safety include:

  • Greatly increased availability of video office visits
  • Ensuring social distancing measures are taken in all waiting areas
  • Continuing the practice of cleaning and disinfecting exams rooms thoroughly between every visit
  • Appropriate personal protective equipment (PPE) for all staff members at our health clinics

AcurianHealth helps connect people with research studies that offer treatment under development. Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.

Terms of Use | Privacy Policy